Literature DB >> 21117388

Managing diabetic nephropathy.

Joanne Shields1, Alexander P Maxwell.   

Abstract

The earliest sign of DN is the development of microalbuminuria which is associated with a significant risk of both progressive renal failure and premature death from cardiovascular disease. Optimal glycaemic and BP control, including the use of RAAS blocking drugs, can prevent, slow and even reverse the processes causing DN.

Entities:  

Mesh：

Year:  2010        PMID： 21117388      PMCID： PMC4952417          DOI： 10.7861/clinmedicine.10-5-500

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


  10 in total

1.  Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

Authors:  Amanda I Adler; Richard J Stevens; Sue E Manley; Rudy W Bilous; Carole A Cull; Rury R Holman
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

2.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

Review 3.  Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.

Authors:  G L Bakris; M Williams; L Dworkin; W J Elliott; M Epstein; R Toto; K Tuttle; J Douglas; W Hsueh; J Sowers
Journal:  Am J Kidney Dis       Date:  2000-09       Impact factor: 8.860

4.  Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes.

Authors:  Empar Lurbe; Josep Redon; Ajit Kesani; Jose Maria Pascual; Jose Tacons; Vicente Alvarez; Daniel Batlle
Journal:  N Engl J Med       Date:  2002-09-12       Impact factor: 91.245

5.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

6.  Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study.

Authors:  Stein Hallan; Brad Astor; Solfrid Romundstad; Knut Aasarød; Kurt Kvenild; Josef Coresh
Journal:  Arch Intern Med       Date:  2007-12-10

7.  Aliskiren combined with losartan in type 2 diabetes and nephropathy.

Authors:  Hans-Henrik Parving; Frederik Persson; Julia B Lewis; Edmund J Lewis; Norman K Hollenberg
Journal:  N Engl J Med       Date:  2008-06-05       Impact factor: 91.245

8.  Telmisartan, ramipril, or both in patients at high risk for vascular events.

Authors:  Salim Yusuf; Koon K Teo; Janice Pogue; Leanne Dyal; Ingrid Copland; Helmut Schumacher; Gilles Dagenais; Peter Sleight; Craig Anderson
Journal:  N Engl J Med       Date:  2008-03-31       Impact factor: 91.245

9.  Effect of a multifactorial intervention on mortality in type 2 diabetes.

Authors:  Peter Gaede; Henrik Lund-Andersen; Hans-Henrik Parving; Oluf Pedersen
Journal:  N Engl J Med       Date:  2008-02-07       Impact factor: 91.245

10.  Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis.

Authors:  G M Magee; R W Bilous; C R Cardwell; S J Hunter; F Kee; D G Fogarty
Journal:  Diabetologia       Date:  2009-02-07       Impact factor: 10.122
  10 in total
  5 in total

1.  Kidney Injury Molecule Levels in Type 2 Diabetes Mellitus.

Authors:  Ozgur Aslan; Metin Demir; Mehmet Koseoglu
Journal:  J Clin Lab Anal       Date:  2016-05-02       Impact factor: 2.352

2.  Genistein attenuates renal fibrosis in streptozotocin‑induced diabetic rats.

Authors:  Qiang Jia; Rui Yang; Xiao-Fen Liu; Shan-Feng Ma; Lei Wang
Journal:  Mol Med Rep       Date:  2018-11-09       Impact factor: 2.952

3.  6-Gingerol, a Bioactive Compound of Ginger Attenuates Renal Damage in Streptozotocin-Induced Diabetic Rats by Regulating the Oxidative Stress and Inflammation.

Authors:  Saleh A Almatroodi; Abdullah M Alnuqaydan; Ali Yousif Babiker; Mashael Abdullah Almogbel; Amjad Ali Khan; Arshad Husain Rahmani
Journal:  Pharmaceutics       Date:  2021-02-28       Impact factor: 6.321

4.  Association of intercellular adhesion molecule 1 (ICAM1) with diabetes and diabetic nephropathy.

Authors:  Harvest F Gu; Jun Ma; Karolin T Gu; Kerstin Brismar
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-22       Impact factor: 5.555

5.  Propyl gallate plays a nephroprotective role in early stage of diabetic nephropathy associated with suppression of glomerular endothelial cell proliferation and angiogenesis.

Authors:  Shaojiang Tian; Junming Tang; Huihui Liu; Liping Wang; Jianming Shen; Junfeng Li; Yanjie Gan
Journal:  Exp Diabetes Res       Date:  2012-09-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.